These findings are in agreement with the results of the present study, in that the prevalence rate of NAFLD was higher in those subjects with GH levels <0.07 ng/mL than in those whose GH levels were higher. The gene discussed is GH1; the disease is metabolic dysfunction-associated steatotic liver disease.